John Abramson

Abramson earned a BA in social relations from Harvard College in 1970, a BMS from Dartmouth Medical School in 1974 and an MD from Brown Medical School in 1976.⁠[1]

In 1982 he took over a fledgling family practice in Hamilton, Massachusetts, where he served as a small-town family doctor for the next 20 years.⁠[2]

He also worked as a family doctor in Appalachia with the National Health Service Corps.⁠[3]

He spent two years as a Robert Wood Johnson Fellow learning to analyze and criticize research articles.⁠[4]

In the mid-1990s he merged his practice with Lahey Clinic, chairing its new Department of Family Practice for seven years; he also taught Harvard Medical School students in his office and co-taught a course with Herbert Benson on the doctor-patient relationship.⁠[2]

In November 2003 he argued that most clinical research had become commercially funded, profit-oriented activity and that the evidence doctors rely on “has become more like infomercials than objective science.”⁠[4]

In September 2004 HarperCollins published his Overdo$ed America: The Broken Promise of American Medicine; a third edition followed in 2008.⁠[3]

Reviewing it for The BMJ, Ray Moynihan said the book traced the author’s path from bewilderment over COX-2 inhibitors to skepticism and stood out for its respect for the healing potential of the doctor-patient relationship, though it lacked a compelling narrative.⁠[5]

From 2005 he served as an expert in litigation involving pharmaceuticals and medical devices.⁠[1]

In February 2006 he delivered an NPR commentary describing how he had found discrepancies between articles on Vioxx and Celebrex in the NEJM and JAMA but had trouble persuading his patients to switch medications.⁠[6]

In 2010 he became a lecturer in Harvard Medical School’s Department of Health Care Policy, having been a clinical instructor there.⁠[1]

As of March 2010 he served as an expert for plaintiffs’ attorneys in litigation involving the pharmaceutical industry and as a consultant to Wells Fargo Health Solutions.⁠[3]

In October 2013 he and colleagues published an analysis in The BMJ questioning the evidence for extending routine statin use to people at low cardiovascular risk; reanalyzing Cholesterol Treatment Trialists’ Collaboration data, they contended that for low-risk people the benefits of statins were smaller than claimed and the risks greater.⁠[7]

On November 14, 2013, he and Rita Redberg published the New York Times op-ed “Don’t Give More Patients Statins,” arguing that the new ACC/AHA guideline’s expansion of statin use would benefit the drug industry more than anyone else; vascular surgery professor Frank Veith wrote in rebuttal that statins have minimal side effects and have repeatedly been shown to prevent heart attacks and strokes.⁠[8]

In May 2014 the authors withdrew a statement, drawn from an observational study, that statin side effects occur in 18% to 20% of patients, because the figure was a misreading; Rory Collins, who led the CTT Collaboration, asked for retraction, and BMJ editor Fiona Godlee referred the decision to an independent panel.⁠[9]

In an editorial Godlee said the true rate of adverse events in low-risk statin users remained disputed and that The BMJ would keep debating wider use.⁠[7]

In August 2014 the independent review panel unanimously found that the two articles did not meet the criteria for retraction, saying the error did not compromise their principal arguments, which were within the range of reasonable opinion; the panel took no position on the risks and benefits of statins themselves.⁠[10]

On February 8, 2022, his Sickening: How Big Pharma Broke American Health Care and How We Can Repair It was published; a review called it a “blistering, persuasive critique” of the harms done when drug companies hide the truth about their drugs.⁠[11]

He appeared on episode 263 of the Lex FridmanLex FridmanLex Fridman is a Soviet-born, US-raised computer scientist and podcast host who works as an MIT research scientist on human-AI interaction and autonomous driving. His Lex Fridman Podcast is known for hours-long conversations with guests including heads of state and technology leaders.Open the full entry Podcast, whose description calls him Harvard Medical School faculty, a family physician for over two decades and the author of the new book Sickening; topics included big pharma, advertising, corruption, Pfizer vaccine data and profits, censorship, the FDA, the NIH and medications.⁠[12]

A review noted that he had served as a legal expert in about 15 civil trials involving drugmakers; in the book he argues that peer review fails for drug development because raw clinical trial data are kept from reviewers and journals, and he calls for a reform coalition of health professionals, payers and consumers.⁠[13]

In 2023 Family Medicine published a review by Elizabeth C. Halloran summarizing how the book uses four cases, rofecoxib, the off-label marketing of gabapentin, statins for people without vascular disease and insulin analogs, to show physicians being led into false beliefs.⁠[14]

Brown UniversityBrown UniversityBrown University is a private nonprofit research university in Providence, Rhode Island, and a member of the Ivy League. Chartered by Rhode Island's colonial legislature in 1764, it is known for its undergraduate Open Curriculum, which has no common required core. Christina H. Paxson, president since July 2012, announced on August 3, 2026, that the 2026–27 academic year would be her last in office. As of October 1, 2026, the search for Brown's 20th president remained underway.Open the full entry’s medical school bookshelf, noting him as an MD’76 alumnus, described the book as building on the work of his first book.⁠[15]

Personal website: Public link: https://hcp.hms.harvard.edu/people/john-david-abramson (opens in a new window)⁠[12]

Harvard Medical School: Official website: https://hms.harvard.edu/ (opens in a new window)⁠[12]